SMAD3 and pancreatic adenocarcinoma: By using mCherry cell signaling reporter lines, the authors observed dysregulated activity of the Notch pathway during the early stages and dysregulation of Smad3/TGFβ and Shh pathways during the later stages of pancreatic adenocarcinoma.